SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-093893
Filing Date
2024-08-08
Accepted
2024-08-08 16:05:37
Documents
13
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K orgo-20240808.htm   iXBRL 8-K 43401
2 EX-99.1 orgo-ex99_1.htm EX-99.1 603423
3 GRAPHIC img36819578_0.jpg GRAPHIC 10498
  Complete submission text file 0000950170-24-093893.txt   808921

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT orgo-20240808.xsd EX-101.SCH 29652
15 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20240808_htm.xml XML 4518
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 241188170
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)